Korea Pharma Manufacturing Association Takes Steps To Snag Unethical Member Companies
This article was originally published in PharmAsia News
Executive Summary
SEOUL - Amid stepped-up government surveillance of the local pharma industry, the Korea Pharmaceutical Manufacturers Association is opening what it calls a "distribution irregularity reporting center," in an effort to stop illegal deals among drug companies, hospitals and pharmacies
You may also be interested in...
Korea's Anti-Rebate Laws Seen Sparking More Demand For MNC Products
SEOUL - Last week's passage of long-awaited "anti-rebate laws" that enable courts to punish both contributors and receivers of rebates, could trigger more demand from doctors to prescribe branded products from multinational companies, industry watchers said
Korea's Anti-Rebate Laws Seen Sparking More Demand For MNC Products
SEOUL - Last week's passage of long-awaited "anti-rebate laws" that enable courts to punish both contributors and receivers of rebates, could trigger more demand from doctors to prescribe branded products from multinational companies, industry watchers said
Korea Pharmaceutical Manufacturers Association President Under Fire For Alleged Kickbacks
SEOUL - Four months after an aggressive declaration that his association would not tolerate any member company involvement in unethical or improper business deals with doctors and hospitals, the president of the Korea Pharmaceutical Manufacturers Association is under fire for his company's alleged kickbacks to doctors